We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 61-80 of 10,000 results
  1. Implementing precision oncology for sarcoma patients: the CCCLMUmolecular tumor board experience

    Purpose

    Due to poor outcomes and limited treatment options, patients with advanced bone and soft tissue sarcomas (BS/STS) may undergo comprehensive...

    Luc M. Berclaz, Anton Burkhard-Meier, ... Lars H. Lindner in Journal of Cancer Research and Clinical Oncology
    Article Open access 05 August 2023
  2. Molecular tumour boards — current and future considerations for precision oncology

    Over the past 15 years, rapid progress has been made in developmental therapeutics, especially regarding the use of matched targeted therapies...

    Apostolia M. Tsimberidou, Michael Kahle, ... Funda Meric-Bernstam in Nature Reviews Clinical Oncology
    Article 16 October 2023
  3. Endoscopic ultrasound-guided tissue acquisition for comprehensive genomic profiling

    Advances in next-generation sequencing have made comprehensive genomic profiling (CGP) using tumor tissue specimens and liquid biopsy using blood...

    Nozomi Okuno, Kazuo Hara in Journal of Medical Ultrasonics
    Article 28 January 2024
  4. Molecular diagnostics in odontogenic tumors

    Background

    Odontogenic tumors (OTs) are rare, with an estimated incidence rate of less than 0.5 cases per 100,000 per year. The causes of OTs remain...

    Reinhard Buettner, Sibel Elif GÃŒltekin in Die Pathologie
    Article Open access 15 November 2022
  5. Profiling joint tissues at single-cell resolution: advances and insights

    Advances in the profiling of human joint tissues at single-cell resolution have provided unique insights into the organization and function of these...

    Akshay Pandey, Nidhi Bhutani in Nature Reviews Rheumatology
    Article 06 December 2023
  6. Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics

    Atypical teratoid/rhabdoid tumors (AT/RT) are the most common malignant brain tumors manifesting in infancy. They split into four molecular types....

    Pascal D. Johann, Lea Altendorf, ... Ulrich SchÃŒller in Acta Neuropathologica
    Article Open access 14 July 2023
  7. Targeted molecular profiling of salivary duct carcinoma with rhabdoid features highlights parallels to other apocrine and discohesive neoplasms: which phenotype should drive classification?

    Background

    Salivary duct carcinoma with rhabdoid features (SDC-RF) is a recently-described salivary gland tumor that bears striking histologic...

    Lisa M. Rooper, Jeffrey Gagan, Justin A. Bishop in Head and Neck Pathology
    Article 06 July 2022
  8. Genomic and TCR profiling data reveal the distinct molecular traits in epithelial ovarian cancer histotypes

    Epithelial ovarian cancer (EOC) is classified into five major histotypes: high-grade serous (HGSOC), low-grade serous (LGSOC), clear cell (CCOC),...

    Shan Zhu, Chunliu Zhang, ... Yang **ang in Oncogene
    Article 25 April 2022
  9. Comprehensive profiling of enhancer RNA in stage II/III colorectal cancer defines two prognostic subtypes with implications for immunotherapy

    Background

    Recently, enhancer RNAs (eRNAs) have garnered attention as pivotal biomarkers for the onset and progression of cancer. However, the...

    **aoyun Bu, Shuang Liu, ... Yingbin Hu in Clinical and Translational Oncology
    Article 12 September 2023
  10. High-Grade Endometrial Cancer: Molecular Subtypes, Current Challenges, and Treatment Options

    Although many recent advancements have been made in women’s health, perhaps one of the most neglected areas of research is the diagnosis and...

    Yusuke Matoba, Kyle M. Devins, ... Bo R. Rueda in Reproductive Sciences
    Article 24 April 2024
  11. Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets

    Signet ring cell carcinoma (SRCC) is rare: about 10% of gastric cancer (GC) and 1% of colorectal cancer (CRC). SRCC is associated with poor...

    Alberto Puccini, Kelsey Poorman, ... Heinz-Josef Lenz in Oncogene
    Article 26 May 2022
  12. Relationship of Histopathologic Parameters and Gene Expression Profiling in Malignant Melanoma

    Background

    Histopathologic characteristics (HC) are a mainstay in melanoma prognosis; gene expression profiling (GEP) has emerged as a potential...

    Alexis G. Strahan, Ivan Å vagelj, Drazen Jukic in American Journal of Clinical Dermatology
    Article 04 September 2023
  13. Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling

    Background

    Gliosarcoma (GS) refers to the presence of mesenchymal differentiation (as seen using light microscopy) in the setting of glioblastoma (GB,...

    Christopher Dardis, David Donner, ... Surasak Phuphanich in BMC Neurology
    Article Open access 23 June 2021
  14. Differentiating infection, colonisation, and sterile inflammation in critical illness: the emerging role of host-response profiling

    Infection results when a pathogen produces host tissue damage and elicits an immune response. Critically ill patients experience immune activation...

    Mark Jeffrey, Kerina J. Denny, ... Andrew Conway Morris in Intensive Care Medicine
    Article 21 June 2023
  15. Real-world genomic profiling of acute myeloid leukemia and the impact of European LeukemiaNet risk stratification 2022 update

    Background

    Acute myeloid leukemia (AML) is a myeloid neoplasm associated with a high morbidity and mortality. The diagnosis, risk stratification and...

    Susana Elaine Alves da Rosa, Larissa Barbosa de Lima, ... Paulo Vidal Campregher in Clinical and Translational Oncology
    Article 11 May 2023
  16. Evaluating cell culture reliability in pediatric brain tumor primary cells through DNA methylation profiling

    In vitro models of pediatric brain tumors (pBT) are instrumental for better understanding the mechanisms contributing to oncogenesis and testing new...

    Lucia Pedace, Simone Pizzi, ... Evelina Miele in npj Precision Oncology
    Article Open access 18 April 2024
  17. Clinical evaluation of deep learning-based risk profiling in breast cancer histopathology and comparison to an established multigene assay

    Purpose

    To evaluate the Stratipath Breast tool for image-based risk profiling and compare it with an established prognostic multigene assay for risk...

    Yinxi Wang, Wenwen Sun, ... Johan Hartman in Breast Cancer Research and Treatment
    Article Open access 09 April 2024
  18. Multimodal classification of molecular subtypes in pediatric acute lymphoblastic leukemia

    Genomic analyses have redefined the molecular subgrou** of pediatric acute lymphoblastic leukemia (ALL). Molecular subgroups guide...

    Olga Krali, Yanara Marincevic-Zuniga, ... Jessica Nordlund in npj Precision Oncology
    Article Open access 08 December 2023
  19. Precision Medicine for the Treatment of Colorectal Cancer: the Evolution and Status of Molecular Profiling and Biomarkers

    Purpose of Review

    The application of advanced genomic testing to develop tumor-specific molecular profiles is essential to facilitating precision...

    May Cho, Ryan Beechinor, ... Axel Grothey in Current Colorectal Cancer Reports
    Article 22 July 2021
  20. Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan

    Background

    The human epidermal growth factor receptor 2 (HER2) negative luminal B1 subtype of breast cancer has been reported with a poorer outcome...

    Bo-Fang Chen, Yi-Fang Tsai, ... Chi-Cheng Huang in Breast Cancer
    Article 09 December 2023
Did you find what you were looking for? Share feedback.